甲状腺髓癌的综合DNA甲基化分析:分子分类,潜在的治疗标和分类系统
Cenkai Shen1, Xiao Shi1, Duo Wen1
1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China.
概括
我们确定了三种独特的甲状腺髓癌 (MTC) 的表观基因组亚型和一个新的治疗点NNAT. 这项研究为未来的MTC研究和临床应用提供了框架.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 甲状腺髓性癌 (MTC) 是一种罕见的,异质的甲状腺癌,治疗选择有限.
- 晚期疾病在MTC中很常见,需要改进临床管理策略.
- DNA甲基化分析为了解MTC生物学提供了一种临床上可访问的方法.
研究的目的:
- 构建迄今为止最大的甲基化瘤甲状腺癌 (MTC) 队列.
- 确定MTC的新型分子分类和治疗点.
- 开发一个MTC风险分层的预测模型.
主要方法:
- 对78个MTC甲基化样本进行了全面分析.
- 机器学习,统计分析和体外实验的整合.
- 转录组集成以表观基因组集群的特征.
主要成果:
- 基于表观基因异质性的三类MTC聚类系统的识别.
- 显著的甲基化模式标志着MTC-A,MTC-B和MTC-C亚型.
- 在预后不佳的MTC中,NNAT表达减少,其治疗潜力在体外验证.
- 开发一个68探针弹性网物流回归模型用于MTC预测.
结论:
- 这项研究为骨髓甲状腺癌研究提供了强大的资源和框架.
- 鉴定的表观基因组亚型和NNAT标为MTC治疗提供了新的途径.
- 预测模型的进一步验证和临床应用是合理的.
相关概念视频
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


